Evaluation of The Clinical Effectiveness of Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib And Best Supportive Care (BSC) In Previously Treated Advanced or Metastatic Renal Cell Carcinoma (AMRCC)- A Systematic Review And Mixed-Tre ...
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.105
https://www.valueinhealthjournal.com/article/S1098-3015(17)30439-4/fulltext
Title :
Evaluation of The Clinical Effectiveness of Axitinib, Cabozantinib, Everolimus, Nivolumab, Sunitinib And Best Supportive Care (BSC) In Previously Treated Advanced or Metastatic Renal Cell Carcinoma (AMRCC)- A Systematic Review And Mixed-Tre ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30439-4&doi=10.1016/j.jval.2017.08.105
First page :
A415
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
84